118 results
Page 5 of 6
6-K
EX-99.1
zhxqw3qinut3s59n7 bu
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
72pydubr32fb4psfc9w
23 Jan 14
BioLineRx Receives Orphan Drug
12:00am
6-K
EX-99
7d3crza8pok0xq3
13 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
wlsjq p4x
16 Dec 13
BioLineRx Announces Promising Initial Phase 2
12:00am
6-K
EX-99
e347pq s0k
10 Dec 13
BioLineRx Presents Positive Preclinical Results of
12:00am
6-K
EX-99
iic3 3zlh82
19 Nov 13
BioLineRx Reports Publication in Peer Review Journal
12:00am
6-K
EX-99
hgtv6ap0k1gyg
9 Sep 13
BioLineRx’s BL-8040 Receives Orphan Drug
12:00am
6-K
EX-99
ldviulzudhmrt7pcspf
3 Sep 13
BioLineRx Announces Issuance of United States Patent
12:00am
424B3
abjo63nzxvhfv9r7 b2
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
2a8wtc r1
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
0t5x3 c7sb
5 Aug 13
BioLineRx Announces Publication of Positive
12:00am
6-K
EX-99
3gswmq9u
6 Jun 13
Current report (foreign)
12:00am
6-K
EX-99
hbh ncnrvzy5
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
6-K
EX-99
68vy3zd6h
10 Apr 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
424B5
5gdrvoqn mxg
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
v19a0o
15 Oct 12
Prospectus supplement
12:00am
F-1
5hlom62ft3y2 dy
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99.1
1ce3ybi8883
4 Sep 12
Current report (foreign)
12:00am
424B3
rmumxi7jv
28 Mar 12
Prospectus supplement
12:00am